Jane Street Group LLC Sells 50,172 Shares of Medifast, Inc. (NYSE:MED)

Jane Street Group LLC cut its stake in shares of Medifast, Inc. (NYSE:MED - Free Report) by 31.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 110,917 shares of the specialty retailer's stock after selling 50,172 shares during the period. Jane Street Group LLC owned about 1.01% of Medifast worth $1,954,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Wells Fargo & Company MN lifted its position in Medifast by 23.5% during the fourth quarter. Wells Fargo & Company MN now owns 6,459 shares of the specialty retailer's stock valued at $114,000 after purchasing an additional 1,227 shares in the last quarter. Nisa Investment Advisors LLC raised its holdings in Medifast by 2,308.8% during the fourth quarter. Nisa Investment Advisors LLC now owns 11,442 shares of the specialty retailer's stock valued at $202,000 after acquiring an additional 10,967 shares during the period. Barclays PLC raised its holdings in Medifast by 15.1% during the fourth quarter. Barclays PLC now owns 16,194 shares of the specialty retailer's stock valued at $285,000 after acquiring an additional 2,127 shares during the period. Exchange Traded Concepts LLC raised its holdings in Medifast by 4.1% during the fourth quarter. Exchange Traded Concepts LLC now owns 17,106 shares of the specialty retailer's stock valued at $301,000 after acquiring an additional 674 shares during the period. Finally, Amundi bought a new stake in Medifast during the fourth quarter valued at about $374,000. 95.51% of the stock is currently owned by hedge funds and other institutional investors.

Medifast Stock Up 1.6%

NYSE:MED traded up $0.21 on Thursday, reaching $13.45. 213,658 shares of the company's stock traded hands, compared to its average volume of 296,420. The stock has a 50-day simple moving average of $13.11 and a 200-day simple moving average of $15.54. The firm has a market cap of $147.83 million, a PE ratio of 74.72 and a beta of 0.96. Medifast, Inc. has a 12 month low of $11.57 and a 12 month high of $26.53.

Medifast (NYSE:MED - Get Free Report) last issued its earnings results on Monday, April 28th. The specialty retailer reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($0.04). Medifast had a return on equity of 10.64% and a net margin of 0.35%. The firm had revenue of $115.73 million during the quarter, compared to the consensus estimate of $114.85 million. On average, equities analysts anticipate that Medifast, Inc. will post 0.51 earnings per share for the current year.

Wall Street Analyst Weigh In

MED has been the topic of a number of recent analyst reports. Wall Street Zen raised Medifast from a "hold" rating to a "buy" rating in a report on Thursday, May 1st. DA Davidson decreased their price target on Medifast from $17.00 to $16.50 and set a "neutral" rating on the stock in a report on Wednesday, February 19th.

Medifast Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.